InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,192.56
(
0.23%
)
US TECH 100
17,610.80
(
0.00%
)
Dow Jones
38,904.81
(
0.14%
)
Brent Oil
82.90
(
-0.69%
)
Bitcoin
63,657.99
(
0.79%
)
Post# of 294
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

trendzone

Send PM Follow Ignore
Followers 57
Posts 4855
Boards Moderated 0
Alias Born 02/11/2020

trendzone

Re: None

Thursday, 12/09/2021 2:45:35 PM

Thursday, December 09, 2021 2:45:35 PM

Post# of 294
Viatris (VTRS) “could combine biosimilars with Biocon and keep the optionality on IPO - doesn’t have to decide now.” the analyst wrote, adding $4 per share estimated for biosimilar business to indicate over $20 per share value for the company.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent VTRS News
More VTRS News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Start posting your company's news
Only $200 per official company press release!